Replies to post #221719 on Biotech Values

[rfj1862]

Strikes me as an absolutely terrible idea.

This strategy is obviously great for people with deficiency diseases (like hemophilia), not so good to produce therapeutic proteins.

[jellybean]

cost and efficacy. DNA plasmids to drive an immune response are formulated in saline solution and cost pennies to make. efficacy is enhanced by the continuous production and the lack of ADAs, because they are completely human and as was pointed out, proteins that go through the cell's machinery are usually not targeted for attack.